ARCHIVES

Capitated Oncology Becomes Marketplace Reality Wit Plan By Companies

This article is from The Cancer Letter archive.

Vol. 20 No. 02 | January 14, 1994

Download PDF Visit The Full Archive

Related Articles

California Weighs Listing Tamoxifen As Carcinogen

October 27, 1995

William Tipping New ACS Executive VP; Murphy To Replace Holleb, Laszio Takes Rauscher’s Position

March 4, 1988

Letter: Medicare Policy May Delay Access to Cancer Drugs

June 13, 2003

AIDS Research Loan Repayment Program

January 10, 1992

Lederberg Appointment As Panel Chairman Confirmed; Bernard Fisher will Be Names To The Other Vacancy

November 30, 1979

In Brief: Pazdur to direct FDA Oncology Division; Ganz Awarded ACS Clinical Professorship

July 23, 1999